Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-01-16 @ 1:53 AM
Study NCT ID:
NCT02569320
Status:
COMPLETED
Last Update Posted:
2021-06-15
First Post:
2015-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-03
First Submit QC Date:
None
Study First Post Date:
2015-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-10
Last Update Post Date:
2021-06-15
Last Update Post Date Type:
ACTUAL